Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
05/2003
05/30/2003CA2467559A1 Topical delivery of codrugs
05/30/2003CA2467551A1 Benzothiazole derivatives as adenosine receptor ligands
05/30/2003CA2467242A1 Treatment of immunological disorders using anti-cd30 antibodies
05/30/2003CA2467206A1 Genes encoding g-protein coupled receptors and methods of use therefor
05/30/2003CA2467104A1 A plant extract active as an immunostimulating agent
05/30/2003CA2467053A1 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
05/30/2003CA2466733A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
05/30/2003CA2466491A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
05/30/2003CA2464867A1 Pharmaceutical and cosmetic compositions containing oxy group-bearing aromatic aldehydes
05/30/2003CA2463790A1 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use
05/29/2003US20030100772 Oxygen-containing heterocyclic compounds
05/29/2003US20030100764 Thioether substituted imidazoquinolines
05/29/2003US20030100608 1,4-disubstituted benzo-fused cycloalkyl urea compounds
05/29/2003US20030100607 Thiolalkyl benzoic acid derivatives
05/29/2003US20030100603 Administering to the patient subject to a C-reactive protein associated inflammatory condition, an effective amount of a non-alpha-tocopherol enriched tocopherol
05/29/2003US20030100599 2-amino-fluorene derivatives useful for prophylactic and/or therapeutic treatment of diseases and conditions associated with alpha 4 intergrins or their ligands
05/29/2003US20030100594 Carbonic anhydrase inhibitor
05/29/2003US20030100588 Indole-type inhibitors of p38 kinase
05/29/2003US20030100585 For example 3-(2-(1-(2-(3-Methoxy-4-(3-o-tolyl-ureido)-phenyl)-acetylamino )- 3-methyl-butyl)-4,5-dihydro-oxazol-5-yl)-2-methyl-propionic acid
05/29/2003US20030100581 Norastemizole polymorphs
05/29/2003US20030100571 Such as 2-((6-(((4-(3,4-dimethoxyphenyl)methyl)amino)-7-ethyl-7H-purin-2-yl)amino) -4,5-methyl-N-phenyl-5-thiazole-carboxamide for treatment of lymphocyte mediated diseases such as transplant rejection and graft versus host disease
05/29/2003US20030100570 Immunomodulation and effect on cell processes relating to serotonin family receptors
05/29/2003US20030100563 Such as 7-((3R)-3-amino-4-(3,4-difluorophenyl)butanoyl)-2-(trifluoromethyl)-5,6,7,8 -tetrahydroimidazo(1,2-a)pyrazine dihydrochloride for treatment of insulin resistance disorders
05/29/2003US20030100548 Antiarthritic agents; atherosclerosis and chronic obstructive pulmonary disease treatments
05/29/2003US20030100537 Calcium (3S) tetrahydro-3-furanyl (1S,2R)-3-[[(4-aminophenyl)sulfonyl](isobutyl)amino]-1-benzyl-2-(phos-phonooxy)propylcarbamate
05/29/2003US20030100527 Immunostimulatory nucleic acid molecules for activating dendritic cells
05/29/2003US20030100517 For therapy of diseases involving fungal or suspected fungal infection, for immunomodulation or immunosuppression in conditions in which fungal or suspected fungal colonisation of e.g.skin plays a role
05/29/2003US20030100510 Crystallized structure of type IV collagen NC1 domain hexamer
05/29/2003US20030100490 For therapy of arthritis, inflammatory dermatosis, inflammatory bowel disease, cancer, kidney fibrosis, inflammatory lung disease, obesity, lupus, cardiovascular disease and diabetes mellitus
05/29/2003US20030099992 Genes associated with mast cell activation
05/29/2003US20030099765 Process for coating a surface of a stent
05/29/2003US20030099747 Thickened oil compositions of edible oil
05/29/2003US20030099712 Therapeutic coating for an intravascular implant
05/29/2003US20030099675 Comprising 9-90% by weight monoglyceride compound, 0.01-90% by weight emulsifier, 0-50% by weight water-insoluble material, 0-90.9% by weight of organic solvent; drug delivery
05/29/2003US20030099668 Comprises loading (transfection) immunogenic DNA oligonucleotides for enhanced lymphocyte response; genetic engineering
05/29/2003US20030099663 Also comprises neuroactive compounds, hormones, compounds having growth hormone acitivity, and polypeptide; vaccines
05/29/2003US20030099661 Compositions and methods for the treatment of immune related diseases
05/29/2003US20030099660 For regenerating tissues; antiaging agents; medical diagnosis; monitoring chemotherapy
05/29/2003US20030099659 Comprises glycerides for mucosal administration; provides enhanced adhesion and absorption
05/29/2003US20030099654 Comprises antibodies/proteins providing inhibition of prothrombinase; treatment and prevention of bacterial and viral infections, allograft/xenograft rejection, glomerulo-nephritis, cancer, gastrointestinal diseases, and fetal loss
05/29/2003US20030099636 Administration of an activated form of ultra-low doses of antibodies to an antigen, wherein said activated form is obtained using homeopathic techniques; for example, treating drug dependence/drug withdrawal; side effect reduction
05/29/2003US20030099635 Use of oral gammaglobulin for the treatment of immune-mediated diseases
05/29/2003US20030099621 Screening cells to identify stem cells having a beneficial gene, and transplanting the cells into a patient to treat HIV or AIDS
05/29/2003US20030099609 Canine IL-4 nucleic acid molecules and uses thereof
05/28/2003EP1314741A1 Bispecific anti-CD19 x anti-CD16 antibodies and uses thereof
05/28/2003EP1314721A1 Novel propenohydroxamic acid derivatives
05/28/2003EP1314719A1 Benzoic acid derivatives and drugs containing the same as the active ingredient
05/28/2003EP1314429A2 Use of an antiretroviral compound to manufacture a medicament for the treatment of sjogren's syndrome, systematic lupus erythematosis, scleroderma, or juvenile rheumatoid arthritis
05/28/2003EP1313875A2 Method of diagnosing, monitoring, staging, imaging and treating colon cancer
05/28/2003EP1313857A2 Lipid metabolism molecules
05/28/2003EP1313854A2 Transporters and ion channels
05/28/2003EP1313853A2 Modulation of fas and fasl expression
05/28/2003EP1313843A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
05/28/2003EP1313769A2 Antibodies to human il-1 beta
05/28/2003EP1313738A1 Process for the preparation and purification of thiol-containing maytansinoids
05/28/2003EP1313736A2 Condensed pyrazindione derivatives
05/28/2003EP1313733A1 Pyrazolopyridine compound and pharmaceutical use thereof
05/28/2003EP1313730A1 Pyrrolidine derivatives and their use as chymase inhibitor
05/28/2003EP1313726A1 Quinoline derivatives having vegf inhibiting activity
05/28/2003EP1313721A2 Non-imidazole aryloxyalkylamines as h3 receptor ligands
05/28/2003EP1313718A2 Inhibitors of copper-containing amine oxidases
05/28/2003EP1313711A2 Indazole derivatives as jnk inhibitors
05/28/2003EP1313710A1 Pyrazole derivatives and their use as protein kinase inhibitors
05/28/2003EP1313512A1 Vascular endothelial growth factor 2
05/28/2003EP1313505A1 Hla binding peptides and their uses
05/28/2003EP1313476A2 Sgk2 and sgk3 used as diagnostic and therapeutic targets
05/28/2003EP1313470A1 Novel alicyclic imidazoles as h 3 agents
05/28/2003EP1313461A2 The use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands
05/28/2003EP1313450A1 A method of treating a systemic disease
05/28/2003EP1200112B1 Chemokine binding protein of gammaherpesvirus 68 and methods of use therefor
05/28/2003EP1163239B1 Modified amino-acid amides as cgrp antagonists
05/28/2003EP1146885B1 Pre-conditioning against cell death
05/28/2003EP1107749B1 Fumaric acid derivatives for the treatment of transplant rejection
05/28/2003EP1032415B1 Composition for the treatment of allergic conditions with cysteine and serine proteinase inhibitors
05/28/2003EP0969833B1 Extension of the expression of transgenic proteins by immunomodulation with 15-deoxyspergualine with 15-deoxyspergualine
05/28/2003EP0941100B1 Pharmaceutical compositions containing lamivudine and zidovudine
05/28/2003EP0814828B1 Method of preparation a therapeutic agent for the regeneration of oligodendrocytes
05/28/2003EP0814792B1 Mercapto and seleno derivatives as inhibitors of nitric oxide synthase
05/28/2003EP0788509B1 Therapeutic peptide derivatives
05/28/2003EP0788360B1 Boronic ester and acid compounds, synthesis and uses
05/28/2003EP0690715B1 Topical and systemic application of buspirone or derivatives thereof for treatment of pathological conditions associated with immune responses
05/28/2003CN1420891A Pharmaceutical compound
05/28/2003CN1420889A Pharmaceutically active isoindoline derivs.
05/28/2003CN1420888A Substd. pyrazoloÒÇö4,3-eÒÇòdiazepines, pharmaceu-tical compositions contg. them, use as medicinal products and processes for preparing them
05/28/2003CN1420884A 2-substd. 4-heteroaryl-pyrimidines and their use in treatment of proliferative disorders
05/28/2003CN1420881A Beta-amino acid derivs. as inhibitors of matrix metalloproteases and TNF-alpha
05/28/2003CN1420878A Compound with growth hormone releasing properties
05/28/2003CN1420872A Caspase inhibitors and use thereof
05/28/2003CN1420797A Method for improvement of islet signaling in diabetes mellitus and for its prevention
05/28/2003CN1420790A Transporters and drug delivery system by using same
05/28/2003CN1420782A Immune enhancing compositions
05/28/2003CN1420779A Nucleoside analogs with carboxamidine-modified bicyclic base
05/28/2003CN1420770A Method of delivery of cetyl myristoleate
05/28/2003CN1420723A Compositions and methods for L-nucleosides, and their analogs
05/28/2003CN1419929A Method for preparing Chinese medicine composition for treating tetanic rachitis complicated necrosis of femoral head
05/28/2003CN1419928A Chinese medicine composition for treating tetanic rachitis complicated necrosis of femoral head
05/28/2003CN1419910A Oral cavity disintegrating tablet of chlorphenamine for treating allergy, and preparing method thereof
05/28/2003CN1109554C Medicine for treating allergic purpura
05/27/2003US6570002 Inhibitor of programmed cell death
05/27/2003US6569997 Antibody specific for H4-1BB
1 ... 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 732 733 734 735 ... 1172